Serum cytokines and bone metabolism in patients with thyroid dysfunction

Advances in Therapy

Volumn 23, Issue 3, 2006, Pages 475-480

  Sekeroglu, M Ramazan ^a   Altun, Z Büsra ^a   Algün, Ekrem ^a   Dülger, Haluk ^a   Noyan, Tevfik ^a   Balaharoglu, Ragip ^a   Öztürk, Mustafa ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Bone turnover marker; Hyperthyroidism; Hypothyroidism; IL 6; Tnf

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CREATININE; CYTOKINE; DEOXYPYRIDINOLINE; INTERLEUKIN 6; OSTEOCALCIN; PHOSPHORUS; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOANALYZER; BLOOD SAMPLING; BONE METABOLISM; BONE TURNOVER; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOASSAY; MAJOR CLINICAL STUDY; THYROID DISEASE;

BIOLOGICAL MARKERS; BONE AND BONES; CALCIUM; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; INTERLEUKIN-6; THYROID FUNCTION TESTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748770682     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850169     Document Type: Article

References (15)

1. Dinarello CA, Moldawer LL. Proinflammatory and Anti-inflammatory Cytokines in Rheumatoid Arthritis. 2nd ed. Thousand Oaks, Calif: Amgen Inc.; 2000:3-23.
2. Ganong WF. Review of Medical Physiology. 20th ed. New York, NY: McGraw-Hill; 2001:307-321.
3. Siddiqi A, Burrin JM, Wood DF, Monson JP. Tri-iodothyronine regulates the production of interleukin-6 and interleukin-8 in human bone marrow stromal and osteoblast-like cells. J Endocrinol. 1998;157:453-461.
4. Siddiqi A, Monson JP, Wood DF, Besser GM, Burrin JM. Serum cytokines in thyrotoxicosis. J Clin Endocrinol Metab. 1999;84:435-439.
5. Lakatos P, Foldes J, Horvath C, et al. Serum interleukin-6 and bone metabolism in patients with thyroid function disorders. J Clin Endocrinol Metab. 1997;82:78-81.
6. Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol. 1990;144:4226-4230.
7. Ishimi Y, Miyaura C, Jin CH, et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol. 1990;145:3297-3303.
8. Bartalena L, Brogioni S, Grasso L, et al. Interleukin-6: a marker of thyroid-destructive processes? J Clin Endocrinol Metab. 1994;79:1424-1427.
9. Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 1994;78:423-427.
10. Fenkci S, Corapcioglu D, Erdogan G. The effects of thyrotoxicosis on serum IL-6 and bone turnover in premenopausal women. Turk J Endocrinol Metab. 2001;3:97-101.
11. Celik I, Akalin S, Erbas T. Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment. Eur J Endocrinol. 1995;132:668-672.
12. van der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab. 1990;71:1567-1572.
13. Pang XP, Hershman JM, Mirell CJ, Pekary AE. Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-alpha (cachectin). Endocrinology. 1989;125:767-784.
14. Ozawa M, Sato K, Han DC, Kawakami M, Tsushima T, Shizume K. Effects of tumor necrosis factor-alpha/cachectin on thyroid hormone metabolism in mice. Endocrinology. 1988;23:1461-1467.
15. Chopra IJ, Sakane S, Teco GN. A study of the serum concentration of tumor necrosis factor-alpha in thyroidal and non-thyroidal illnesses. J Clin Endocrinol Metab. 1991;72:1113-1116.